These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 4355999)
1. The metabolism of cholestanol, cholesterol, and bile acids in cerebrotendinous xanthomatosis. Salen G; Grundy SM J Clin Invest; 1973 Nov; 52(11):2822-35. PubMed ID: 4355999 [TBL] [Abstract][Full Text] [Related]
2. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis. Salen G; Shefer S; Tint GS Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073 [TBL] [Abstract][Full Text] [Related]
3. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis. Clarenbach JJ; Lindenthal B; Dotti MT; Federico A; Kelleher JK; von Bergmann K Metabolism; 2005 Mar; 54(3):335-44. PubMed ID: 15736111 [TBL] [Abstract][Full Text] [Related]
4. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058 [TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of 5 -cholestan-3 -ol in cerebrotendinous xanthomatosis. Salen G; Polito A J Clin Invest; 1972 Jan; 51(1):134-40. PubMed ID: 4550120 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. Grundy SM; Ahrens EH; Salen G; Schreibman PH; Nestel PJ J Lipid Res; 1972 Jul; 13(4):531-51. PubMed ID: 5041275 [TBL] [Abstract][Full Text] [Related]
7. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. Nakamura T; Matsuzawa Y; Takemura K; Kubo M; Miki H; Tarui S Metabolism; 1991 Jul; 40(7):741-6. PubMed ID: 1908036 [TBL] [Abstract][Full Text] [Related]
8. A novel route for the biosynthesis of cholestanol, and its significance for the pathogenesis of cerebrotendinous xanthomatosis. Skrede S; Bjørkhem I Scand J Clin Lab Invest Suppl; 1985; 177():15-21. PubMed ID: 3865344 [TBL] [Abstract][Full Text] [Related]
9. Isolation of 5 alpha-cholestane-3 beta, 7 alpha-diol from bile of patients with cerebrotendinous xanthomatosis. Inefficiency of this steroid as a precursor to cholestanol. Björkhem I; Buchmann MS; Skrede S Biochim Biophys Acta; 1983 Sep; 753(2):220-6. PubMed ID: 6412759 [TBL] [Abstract][Full Text] [Related]
11. A case of cerebrotendinous xanthomatosis. II: The sterol content of a cataractous lens. McKenna P; Morgan SJ; Bosanquet RC; Laker MF Br J Ophthalmol; 1990 Oct; 74(10):629-30. PubMed ID: 2285688 [TBL] [Abstract][Full Text] [Related]
13. Relationships between plasma lipoprotein cholesterol concentrations and the pool size and metabolism of cholesterol in man. Miller NE; Nestel PJ; Clifton-Bligh P Atherosclerosis; 1976; 23(3):535-47. PubMed ID: 178328 [TBL] [Abstract][Full Text] [Related]
15. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge. Björkhem I; Hansson M Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109 [TBL] [Abstract][Full Text] [Related]
16. Genetically and clinically confirmed atypical cerebrotendinous xanthomatosis with normal cholestanol and marked elevations of bile acid precursors and bile alcohols. DeBarber AE; Schaefer EJ; Do J; Ray JW; Larson A; Redder S; Fowler M; Duell PB J Clin Lipidol; 2024; 18(3):e465-e476. PubMed ID: 38637260 [TBL] [Abstract][Full Text] [Related]
17. Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and tissue deposition. Bhattacharyya AK; Lin DS; Connor WE J Lipid Res; 2007 Jan; 48(1):185-92. PubMed ID: 17012751 [TBL] [Abstract][Full Text] [Related]
18. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. Salen G; Berginer V; Shore V; Horak I; Horak E; Tint GS; Shefer S N Engl J Med; 1987 May; 316(20):1233-8. PubMed ID: 3106810 [TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis. Ballantyne CM; Vega GL; East C; Richards G; Grundy SM Metabolism; 1987 Mar; 36(3):270-6. PubMed ID: 3821507 [TBL] [Abstract][Full Text] [Related]
20. Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis. Tint GS; Salen G J Lipid Res; 1982 May; 23(4):597-603. PubMed ID: 7097124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]